| 000 | 01912 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513131749.0 | ||
| 264 | 0 | _c19971230 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1700964 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeconinck, E | |
| 245 | 0 | 0 |
_aAllogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan). _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cNov 1997 |
||
| 300 |
_a731-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aBurkitt Lymphoma _xradiotherapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytarabine _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia-Lymphoma, Adult T-Cell _xradiotherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xtherapeutic use |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xradiotherapy |
| 650 | 0 | 4 | _aWhole-Body Irradiation |
| 700 | 1 | _aCahn, J Y | |
| 700 | 1 | _aMilpied, N | |
| 700 | 1 | _aJouet, J P | |
| 700 | 1 | _aVernant, J P | |
| 700 | 1 | _aEsperou, H | |
| 700 | 1 | _aLioure, B | |
| 700 | 1 | _aBordigoni, P | |
| 700 | 1 | _aLeblond, V | |
| 700 | 1 | _aTroussard, X | |
| 700 | 1 | _aCaillot, D | |
| 700 | 1 | _aCordonnier, J M | |
| 700 | 1 | _aHervé, P | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 20 _gno. 9 _gp. 731-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1700964 _zAvailable from publisher's website |
| 999 |
_c9354266 _d9354266 |
||